Blockade of PD-1 immunosuppression boosts CAR T-cell therapy

  • John L
  • Kershaw M
  • Darcy P
N/ACitations
Citations of this article
153Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The presence of an immunosuppressive microenvironment can limit the full potential of adoptive T cell immunotherapy. However, specific blockade of the PD-1 immunosuppressive pathway can significantly enhance the function of gene-modified T cells expressing a chimeric antigen receptor (CAR) leading to enhanced tumor eradication.

Cite

CITATION STYLE

APA

John, L. B., Kershaw, M. H., & Darcy, P. K. (2013). Blockade of PD-1 immunosuppression boosts CAR T-cell therapy. OncoImmunology, 2(10), e26286. https://doi.org/10.4161/onci.26286

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free